FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Evolus, Inc. Stock AnalysisComprehensive stock analysis for Evolus, Inc. (EOLS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEOLS
EOLS
Evolus, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
EOLS
Home🔹Stocks🔹Evolus, Inc.

Evolus, Inc.

EOLS•NASDAQ

Evolus, Inc.

EOLS•NASDAQ
Market cap
$409.62M
Sentiment

Your view on EOLS

Mkt Cap
$409.62M
Sentiment
Your view
EOLS
Evolus, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
EOLS
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Evolus, Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
David Moatazedi
Headquarters
520 Newport Center Drive, Newport Beach, CA, US
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
David Moatazedi
Headquarters
520 Newport Center Drive, Newport Beach, CA, US
Description

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News